Automate Your Wheel Strategy on XNCR
With Tiblio's Option Bot, you can configure your own wheel strategy including XNCR - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol XNCR
- Rev/Share 2.21
- Book/Share 8.3516
- PB 1.4045
- Debt/Equity 0.1095
- CurrentRatio 5.3407
- ROIC -0.1715
- MktCap 836619330.0
- FreeCF/Share -1.8957
- PFCF -5.9413
- PE -4.8986
- Debt/Assets 0.0772
- DivYield 0
- ROE -0.2673
- Rating C
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 1
- P/B Score 4
- D/E Score 3
Recent Analyst Ratings
Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
---|---|---|---|---|---|---|---|
Resumed | XNCR | Barclays | -- | Underweight | -- | $6 | Sept. 17, 2025 |
Downgrade | XNCR | BofA Securities | Buy | Neutral | -- | $12 | Sept. 3, 2025 |
Initiation | XNCR | William Blair | -- | Outperform | -- | -- | April 21, 2025 |
Initiation | XNCR | Wells Fargo | -- | Overweight | -- | $37 | Dec. 12, 2024 |
News
Strength Seen in Xencor (XNCR): Can Its 7.3% Jump Turn into More Strength?
Published: September 18, 2025 by: Zacks Investment Research
Sentiment: Positive
Xencor (XNCR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Read More
Xencor (XNCR) Reports Q1 Loss, Tops Revenue Estimates
Published: May 07, 2025 by: Zacks Investment Research
Sentiment: Negative
Xencor (XNCR) came out with a quarterly loss of $0.66 per share versus the Zacks Consensus Estimate of a loss of $0.63. This compares to loss of $1.11 per share a year ago.
Read More
Xencor (XNCR) Upgraded to Buy: Here's Why
Published: April 10, 2025 by: Zacks Investment Research
Sentiment: Positive
Xencor (XNCR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Read More
About Xencor, Inc. (XNCR)
- IPO Date 2013-12-03
- Website https://www.xencor.com
- Industry Biotechnology
- CEO Bassil I. Dahiyat
- Employees 250